Cotización CaixaBank - CABKE

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

5.30

Postura de Compra

5.29

Postura de Venta

5.294

Volume Operado de la Acción

1,285,899

5.22 Rango del Día 5.476

0.00 Rango de 52 semanas 0.00

Precio Anterior

5.426

Precio de Apertura

5.474

Hora

224

5.3

Última hora de negociación

08:22:03

Volumen promedio (3 m)

Volumen financiero

6,812,976 €

Precio Promedio Ponderado

5.2982

Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020

BOULDER, Colo., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering

BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Pa...

Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis All primary and secondary endpoints were met and achieved statistical...

Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update

BOULDER, Colo., May 13, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020

BOULDER, Colo., May 04, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

BOULDER, Colo., March 18, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech to Report Fourth Quarter and Full Year 2019 Financial Results on March 18, 2020

BOULDER, Colo., March 09, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Late-Breaking Oral Presentation at 2020 American Academy of Dermatology Annual Meeting by its Asia...

BOULDER, Colo., March 04, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Primary Ax...

BOULDER, Colo., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Settlement of Dispute with Bodor Labs and Entry into Equity Funding Agreements

BOULDER, Colo., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. and its subsidiary (collectively, “Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ISOFOSIsofol Medical AB	SEK 2.765 (56.57%)	71.14k
AG1DAUTO1 Group	7.895 € (15.42%)	20.68k
TMVDTeamViewer SE	12.245 € (11.78%)	46.89k
JDEPAJDE Peets NV	20.42 € (10.86%)	74.52k
TKWYAJust Eat Takeaway.com N.V.	11.96 € (10.54%)	213.21k
LOCALPSolocal Groupe	0.0035 € (-35.19%)	11.18M
2HRADH & R GmbH & Co	4.10 € (-18.33%)	197
VAR1DVarta AG	1.971 € (-15.55%)	32.81k
EBUSAEbusco Holding NV	1.2135 € (-15.26%)	19.67k
GSC1DGesco SE	13.45 € (-11.51%)	541
LOCALPSolocal Groupe	0.0035 € (-35.19%)	11.18M
CABKECaixaBank SA	5.30 € (-2.32%)	1.29M
ISPMIntesa Sanpaolo Spa	3.77 € (-0.70%)	1.18M
BBVAEBanco Bilbao Vizcaya Argentaria SA	9.778 € (-4.09%)	1.03M
FINGBSFingerprint Cards AB	SEK 0.0761 (0.00%)	850.08k